Orchard Therapeutics plc (ORTX)
Jan 24, 2024 - ORTX was delisted (reason: acquired by Kyowa Kirin)
16.70
0.00 (0.00%)
Last trade price

Orchard Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year
20222021202020192018 2017 - 2016
Cash & Equivalents
68.4255.9155.1419.05335.84
Upgrade
Short-Term Investments
75.33164.2136.81305.940
Upgrade
Cash & Cash Equivalents
143.75220.11191.95324.99335.84
Upgrade
Cash Growth
-34.69%14.67%-40.94%-3.23%273.76%
Upgrade
Receivables
8.471.480.881.442.1
Upgrade
Inventory
3.40000
Upgrade
Other Current Assets
12.5353.7330.7123.4617.57
Upgrade
Total Current Assets
168.15275.32223.54349.9355.52
Upgrade
Property, Plant & Equipment
30.9129.0834.627.015.48
Upgrade
Long-Term Investments
4.224.274.274.263.84
Upgrade
Goodwill and Intangibles
3.564.153.0800
Upgrade
Other Long-Term Assets
12.089.5915.4618.111.21
Upgrade
Total Long-Term Assets
50.7647.0957.449.3910.53
Upgrade
Total Assets
218.91322.41280.94399.28366.04
Upgrade
Accounts Payable
9.3210.018.8211.9818.13
Upgrade
Deferred Revenue
11.2712.87000
Upgrade
Current Debt
15.858.1213.85.890
Upgrade
Other Current Liabilities
24.1211.828.9437.9829.78
Upgrade
Total Current Liabilities
60.5742.7951.5655.8647.91
Upgrade
Long-Term Debt
42.2451.3644.3740.020
Upgrade
Other Long-Term Liabilities
17.8418.36.574.216.8
Upgrade
Total Long-Term Liabilities
60.0869.6750.9444.236.8
Upgrade
Total Liabilities
120.64112.46102.5100.0954.7
Upgrade
Total Debt
58.0959.4958.1745.910
Upgrade
Debt Growth
-2.35%2.27%26.70%--
Upgrade
Common Stock
973.13956.93783.7750.81598.41
Upgrade
Retained Earnings
-900.88-750.22-605.64-453.66-290.24
Upgrade
Comprehensive Income
26.023.250.372.043.16
Upgrade
Shareholders' Equity
98.26209.95178.43299.19311.34
Upgrade
Net Cash / Debt
85.66160.62133.78279.08335.84
Upgrade
Net Cash / Debt Growth
-46.67%20.06%-52.06%-16.90%273.76%
Upgrade
Net Cash Per Share
0.671.301.352.9914.89
Upgrade
Working Capital
107.58232.53171.97294.04307.61
Upgrade
Book Value Per Share
7.6816.9417.9432.09138.01
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).